AstraZeneca PLC (AZN) Stock Forecast
US · Healthcare
Current price
$185.68
Market cap
$287.96B
Mean price target
$224.49
Implied upside
20.9%
Key takeaways
- Analysts rate AstraZeneca PLC a “Strong Buy”, with a mean price target of $224.49 — about 20.9% upside from the current $185.68, based on 10 analysts.
- AZN is trading in the middle of its 52-week range, at 64% of the $137.22–$212.71 band.
Analyst consensus
| Consensus rating | Strong Buy |
|---|---|
| Number of analysts | 10 |
| Mean target | $224.49 |
| High target | $245.00 |
| Low target | $184.00 |
| Rating split (SB / B / H / S / SS) | 2 / 6 / 1 / 0 / 0 |
Price & trading
| Current price | $185.68 |
|---|---|
| Previous close | $183.02 |
| 52-week high | $212.71 |
| 52-week low | $137.22 |
| 50-day average | $185.67 |
| Beta | 0.21 |
See the full AZN breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current AstraZeneca PLC (AZN) share price?
- AstraZeneca PLC last traded at $185.68 with a market capitalisation of about $288.0B.
- What is the analyst price target for AZN?
- The mean analyst price target for AstraZeneca PLC is $224.49, roughly 20.9% above the latest price. The current consensus rating is “Strong Buy”.
- Where can I see AstraZeneca PLC's full financial metrics?
- Luminoso tracks AZN's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.